The activation of this pathway often results from mutations or amplifications in PIK3CA (the gene encoding the catalytic subunit of PI3K) or the loss of function of PTEN, a tumor suppressor that negatively regulates PI3K signaling [96,97]. Here, PIK3CA is linked to neoplasm.